This article reviews the emerging trend of microdosing GLP-1 drugs, examining potential benefits, risks, and the current lack of scientific evidence supporting this approach
Clinical trials show higher doses produce more weight loss on average , but individual responses vary enormously some people lose significant weight at the lowest doses, while others need the maximum
It also increased levels of Faecalibacterium prausnitzii, a key butyrate-producing bacterium with anti-inflammatory properties
The abdomen has a consistent subcutaneous fat layer that allows for predictable absorption
Cells were then incubated with coelenterazine H (5 M) in assay buffer (1 HBSS, 10 mM HEPES, 0.1% (w/v) BSA) for 1 h at room temperature
Variations in dosage can occur based on weight loss goals and individual reactions, making a personalized approach essential for optimal effectiveness